Skip to main content
Premium Trial:

Request an Annual Quote

Carl Feldbaum

Trovagene has appointed Carl Feldbaum to its board. He will chair the company's corporate governance and nominating committee. From 1993 to 2005, Feldbaum was president of the Biotechnology Industry Organization, and he currently is on the boards of Actelion Pharmaceuticals and Exelixis. He also serves as director of BIO Ventures for Global Health, and The Life Sciences Foundation. He previously served as chief of staff to Sen. Arlen Specter of Pennsylvania. 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.